Review
Open access
Sep 2026
Advancements and future directions in transforming therapies of prostate cancer.
ABSTRACT The treatment landscape for advanced prostate cancer (PCa) has significantly evolved in recent years, marked by the introduction of several novel therapies. Targeting the androgen receptor (AR) remains a cornerstone of treatment, with drugs, such as abiraterone and next-generation antiandrogens, providing subs...
Jin-Ge Zhao, Bo Tang, Hao Zeng et al.
· Chinese Medical Journal · 0 citations